USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
27.10
+1.67 (6.57%)
Apr 24, 2025, 4:00 PM EDT - Market closed
USANA Health Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 29, 2025 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Jan '21 Jan 2, 2021 | 2016 - 2020 |
| Revenue | 876.24 | 854.5 | 921.01 | 998.6 | 1,186 | 1,135 | Upgrade
|
| Revenue Growth (YoY) | -2.69% | -7.22% | -7.77% | -15.83% | 4.57% | 6.95% | Upgrade
|
| Cost of Revenue | 170.59 | 161.21 | 176.69 | 193.89 | 217.9 | 209.11 | Upgrade
|
| Gross Profit | 705.65 | 693.29 | 744.32 | 804.71 | 968.57 | 925.53 | Upgrade
|
| Selling, General & Admin | 648.33 | 626.97 | 651.25 | 697.1 | 798.37 | 749.04 | Upgrade
|
| Operating Expenses | 648.33 | 626.97 | 651.25 | 697.1 | 798.37 | 749.04 | Upgrade
|
| Operating Income | 57.32 | 66.32 | 93.07 | 107.61 | 170.19 | 176.49 | Upgrade
|
| Interest Expense | -0.64 | -0.28 | -0.26 | -0.19 | -0.06 | -0.51 | Upgrade
|
| Interest & Investment Income | 9.37 | 11.32 | 9.64 | 3.79 | 2.52 | 2.54 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.07 | -1.01 | 0.01 | -2.59 | -2.01 | -0.57 | Upgrade
|
| Pretax Income | 65.98 | 76.35 | 102.45 | 108.62 | 170.64 | 177.95 | Upgrade
|
| Income Tax Expense | 31.17 | 34.29 | 38.67 | 39.27 | 54.14 | 53.28 | Upgrade
|
| Earnings From Continuing Operations | 34.81 | 42.06 | 63.79 | 69.35 | 116.51 | 124.66 | Upgrade
|
| Minority Interest in Earnings | 0.08 | -0.03 | - | - | - | - | Upgrade
|
| Net Income | 34.9 | 42.03 | 63.79 | 69.35 | 116.51 | 124.66 | Upgrade
|
| Net Income to Common | 34.9 | 42.03 | 63.79 | 69.35 | 116.51 | 124.66 | Upgrade
|
| Net Income Growth | -43.66% | -34.11% | -8.02% | -40.48% | -6.54% | 24.01% | Upgrade
|
| Shares Outstanding (Basic) | 19 | 19 | 19 | 19 | 20 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 19 | 19 | 19 | 20 | 21 | Upgrade
|
| Shares Change (YoY) | -1.19% | -0.95% | 0.18% | -5.08% | -4.29% | -6.84% | Upgrade
|
| EPS (Basic) | 1.83 | 2.20 | 3.31 | 3.60 | 5.78 | 5.89 | Upgrade
|
| EPS (Diluted) | 1.82 | 2.19 | 3.30 | 3.59 | 5.73 | 5.86 | Upgrade
|
| EPS Growth | -43.40% | -33.64% | -8.08% | -37.35% | -2.22% | 32.88% | Upgrade
|
| Free Cash Flow | - | 50.92 | 56.15 | 93.5 | 108.46 | 145.31 | Upgrade
|
| Free Cash Flow Per Share | - | 2.66 | 2.90 | 4.84 | 5.33 | 6.84 | Upgrade
|
| Gross Margin | 80.53% | 81.13% | 80.81% | 80.58% | 81.64% | 81.57% | Upgrade
|
| Operating Margin | 6.54% | 7.76% | 10.11% | 10.78% | 14.34% | 15.55% | Upgrade
|
| Profit Margin | 3.98% | 4.92% | 6.93% | 6.94% | 9.82% | 10.99% | Upgrade
|
| Free Cash Flow Margin | - | 5.96% | 6.10% | 9.36% | 9.14% | 12.81% | Upgrade
|
| EBITDA | 72.34 | 80.86 | 105.77 | 121.01 | 183.23 | 190.24 | Upgrade
|
| EBITDA Margin | 8.25% | 9.46% | 11.48% | 12.12% | 15.44% | 16.77% | Upgrade
|
| D&A For EBITDA | 15.02 | 14.54 | 12.7 | 13.39 | 13.04 | 13.75 | Upgrade
|
| EBIT | 57.32 | 66.32 | 93.07 | 107.61 | 170.19 | 176.49 | Upgrade
|
| EBIT Margin | 6.54% | 7.76% | 10.11% | 10.78% | 14.34% | 15.55% | Upgrade
|
| Effective Tax Rate | 47.24% | 44.91% | 37.74% | 36.15% | 31.72% | 29.94% | Upgrade
|
| Advertising Expenses | - | 4.97 | 4.76 | 5.05 | 12.4 | 9.85 | Upgrade
|
Updated Apr 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.